1. ALNY has corrected by 13% over recent weeks. 2. Current phase indicates stock is under pressure. 3. Positive developments on Vutrisiran fueled earlier bullish sentiment. 4. Aggressive buying is discouraged in the current cycle. 5. Investors should consider hedging their existing ALNY positions.